Results 141 to 150 of about 11,707,023 (237)

Post-Acute COVID-19 Syndrome (PACS) and Exercise Interventions: A Systematic Review of Randomized Controlled Trials. [PDF]

open access: yesSports (Basel)
Presta V   +6 more
europepmc   +1 more source

Redefining CHI3L1: Therapeutic Opportunities at the Crossroads of Immune Suppression and Disease Progression

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Chitinase‐3‐like‐1 (CHI3L1, also known as YKL‐40) has been recognized as a biomarker of inflammation and tissue remodeling and has now emerged as a pseudoenzymatic immune checkpoint. Recent structural, immunological, and translational studies redefine it as an active regulator of immune suppression rather than a passive disease marker. Despite
Kirti Upmanyu   +2 more
wiley   +1 more source

Food and medicine homology: a potential nutritional intervention strategy for post-acute COVID-19 syndrome. [PDF]

open access: yesFront Pharmacol
Li Z   +13 more
europepmc   +1 more source

Gastrointestinal post-acute COVID-19 syndrome. [PDF]

open access: yesNat Rev Gastroenterol Hepatol, 2022
Meringer H, Mehandru S.
europepmc   +1 more source

Improving enteral nutrition in patients requiring neurological intensive care unit care: A retrospective study on a novel bedside nasointestinal tube placement technique

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background This study aimed to develop and assess a bedside nasojejunal tube placement technique designed for resource‐limited settings to address the specific challenges of enteral nutrition (EN) delivery in neurocritical care patients, particularly those at high risk of reflux and aspiration. The technique sought to overcome the drawbacks of
Niuchenglin   +5 more
wiley   +1 more source

Human microbiome in post-acute COVID-19 syndrome (PACS). [PDF]

open access: yesCurr Res Microb Sci
Fallah A   +3 more
europepmc   +1 more source

Post acute CoViD-19 syndrome (PACS) - Long CoViD. [PDF]

open access: yesBioinformation, 2022
Chiappelli F, Fotovat L.
europepmc   +1 more source

Burden of ischemic stroke in China from 1990 to 2050: A systematic review and analysis of Global Burden of Disease Study 2021

open access: yesNeuroprotection, EarlyView.
Based on GBD 2021, the study analyzed the temporal trends of ischemic stroke (IS) burden in China from 1990 to 2021 and forecasted incidence and mortality through 2050. The absolute burden of IS in China will continue to rise by 2050, driven mainly by population aging, with faster age‐standardized incidence rate growth in females than males.
Yijun Zhang   +5 more
wiley   +1 more source

Gut microbiota in post-acute COVID-19 syndrome: not the end of the story. [PDF]

open access: yesFront Microbiol
An Y   +6 more
europepmc   +1 more source

Sicca symptoms in post-acute COVID-19 syndrome. [PDF]

open access: yesOral Dis, 2022
Melo TS   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy